{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:38Z","timestamp":1791655418564,"version":"4.3.4"},"reference-count":128,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The rates of Pneumocystis pneumonia (PcP) are increasing in the HIV-negative susceptible population. Guidance for the prophylaxis and treatment of PcP in HIV, haematology, and solid-organ transplant (SOT) recipients is available, although for many other populations (e.g., auto-immune disorders) there remains an urgent need for recommendations. The main drug for both prophylaxis and treatment of PcP is trimethoprim\/sulfamethoxazole, but resistance to this therapy is emerging, placing further emphasis on the need to make a mycological diagnosis using molecular based methods. Outbreaks in SOT recipients, particularly renal transplants, are increasingly described, and likely caused by human-to-human spread, highlighting the need for efficient infection control policies and sensitive diagnostic assays. Widespread prophylaxis is the best measure to gain control of outbreak situations. This review will summarize diagnostic options, cover prophylactic and therapeutic management in the main at risk populations, while also covering aspects of managing resistant disease, outbreak situations, and paediatric PcP.<\/jats:p>","DOI":"10.3390\/jof4040127","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T09:18:25Z","timestamp":1542878305000},"page":"127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Therapy and Management of Pneumocystis jirovecii Infection"],"prefix":"10.3390","volume":"4","author":[{"given":"P. Lewis","family":"White","sequence":"first","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, UHW, Heath Park, Cardiff CF14 4XW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Price","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, UHW, Heath Park, Cardiff CF14 4XW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Backx","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, UHW, Heath Park, Cardiff CF14 4XW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000\u20132010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1099\/jmm.0.000617","article-title":"Changing epidemiology of Pneumocystis pneumonia, Northern Ireland, UK and implications for prevention, 1 July 2011\u201331 July 2012","volume":"66","author":"Patterson","year":"2017","journal-title":"J. Med. Microbiol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jinf.2016.10.005","article-title":"Estimating the burden of Invasive and Serious Fungal Disease in the United Kingdom","volume":"74","author":"Pegorie","year":"2017","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/infdis\/jiw085","article-title":"Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000\u20132010","volume":"214","author":"Buchacz","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bmt.2015.316","article-title":"The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: A CIBMTR analysis","volume":"51","author":"Williams","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028016650107","article-title":"Pneumocystis jirovecii pneumonia in the non-HIV infected population","volume":"50","author":"Avino","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajt.12947","article-title":"Risk factors of Pneumocystis Pneumonia in Solid Organ recipients in the era of the common use of post transplantation prophylaxis","volume":"15","author":"Iriat","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/acr.20435","article-title":"Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series","volume":"63","author":"Kermani","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RHU.0b013e31829d5017","article-title":"Pneumocystis jirovecii Pneumonia in Systemic Lupus Erythematosus from Southern Taiwan","volume":"19","author":"Weng","year":"2013","journal-title":"J. Clin. Rheumatol."},{"key":"ref_10","first-page":"532","article-title":"Pneumocystis carinii and cytomegalovirus pneumonia after corticosteroid therapy in acute severe alcoholic hepatitis: 2 case reports","volume":"26","author":"Ichai","year":"2002","journal-title":"Gastroenterol. Clin. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00054725-200409000-00025","article-title":"Pneumocystis carinii Pneumonia During Maintenance Anti-Tumor Necrosis Factor-\u03b1 Therapy with Infliximab for Crohn\u2019s Disease","volume":"10","author":"Velayos","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_12","first-page":"e44","article-title":"Pneumocystis jirovecii pneumonia in a patient with pustular psoriasis with an IL-36RN deficiency treated with infliximab: Case report and review of the literature","volume":"58","author":"Podlipnik","year":"2016","journal-title":"Australas. J. Dermatol."},{"key":"ref_13","first-page":"847","article-title":"Autopsy case of pulmonary zygomycosis and Pneumocystis pneumonia in a patient with interstitial pneumonia treated by corticosteroid therapy","volume":"48","author":"Mukasa","year":"2010","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"ref_14","first-page":"860","article-title":"Life threatening Pneumocystis carinii pneumonia in a 4-month-old boy with hyper-IgM syndrome","volume":"141","author":"Heiming","year":"1993","journal-title":"Monatsschr Kinderheilkd"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Plakke, M., Jalota, L., and Lloyd, B. (2013). Pneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: A question of prophylaxis. Case Rep.","DOI":"10.1136\/bcr-2012-007912"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.annder.2016.09.677","article-title":"Dermatomyosite associ\u00e9e aux anticorps anti-MDA5 et pneumocystose pulmonaire: Deux cas d\u2019\u00e9volution fatale","volume":"144","author":"Aymonier","year":"2017","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Van Halem, K., Vrolijk, L., Pereira, A.M., and de Boer, M.G.J. (2017). Characteristics and Mortality of Pneumocystis Pneumonia in patients with Cushing\u2019s syndrome: A Plea for timely initiation of chemoprophylaxis. Open Forum Infect. Dis.","DOI":"10.1093\/ofid\/ofx002"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10620-006-9250-x","article-title":"Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases","volume":"52","author":"Kaur","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/37.suppl_B.33","article-title":"Pneumocystis carinii infection: Current treatment and prevention","volume":"37","author":"Miller","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"6th European Conference on Infections in Leukemia (ECIL-6), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14787210.2017.1305887","article-title":"Diagnosis and management of Pneumocystis jirovecii infection","volume":"15","author":"White","year":"2017","journal-title":"Expert Rev. Anti. Infect. Ther"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jof1030293","article-title":"Pneumocystis Pneumonia in Solid-Organ Transplant Recipients","volume":"1","author":"Iriart","year":"2015","journal-title":"J. Fungi"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59729","DOI":"10.18632\/oncotarget.19927","article-title":"Risk factors for mortality from Pneumocystis carinii pneumonia (PCP) in non-HIV patients: A meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10156-012-0473-9","article-title":"Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy","volume":"19","author":"Hagiya","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/myc.12642","article-title":"Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review","volume":"60","author":"Markantonatou","year":"2017","journal-title":"Mycoses"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1440-1827.2001.01249.x","article-title":"Autopsy case of alcoholic hepatitis and cirrhosis treated with corticosteroids and affected by Pneumocystis carinii and cytomegalovirus pneumonia","volume":"51","author":"Ikawa","year":"2001","journal-title":"Pathol. Int"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2340\/00015555-0977","article-title":"Severe Pneumonia Caused by Combined Infection with Pneumocystis jiroveci, Parainfluenza Virus Type 3, Cytomegalovirus, and Aspergillus fumigatus in a Patient with Stevens-Johnson Syndrome\/toxic Epidermal Necrolysis","volume":"90","author":"Kim","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Dunphy, L., Singh, N., and Keating, E. (2017). Multiple myeloma presenting with bilateral ankle pain (microangiopathy) and complicated by streptococcal meningitis and Pneumocystis carinii pneumonia. BMJ Case Rep.","DOI":"10.1136\/bcr-2016-217289"},{"key":"ref_29","first-page":"81","article-title":"A Case of Pneumonia Caused by Pneumocystis jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T-Cell Leukemia\/Lymphoma: Occam\u2019s Razor Blunted","volume":"80","author":"Desai","year":"2016","journal-title":"Conn. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S2221-1691(11)60056-7","article-title":"A case report of pulmonary coinfection of Strongyloides stercoralis and Pneumocystis jiroveci","volume":"1","author":"Bava","year":"2011","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Burke, J., and Soubani, A. (2017). Influenza and Pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplantation recipient: Coinfection or superinfection?. Transpl. Infect. Dis., 20.","DOI":"10.1111\/tid.12802"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0883073813511148","article-title":"Legionella pneumophila and Pneumocystis jirovecii Coinfection in an Infant Treated with Adrenocorticotropic Hormone for Infantile Spasm","volume":"29","author":"Musallam","year":"2013","journal-title":"J. Child Neurol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2006.20.1","article-title":"Dual Infection with Mycobacterium tuberculosis and Pneumocystis jiroveci Lymphadenitis in a Patient with HIV Infection: Case Report and Review of the Literature","volume":"20","author":"Khawcharoenporn","year":"2006","journal-title":"AIDS Patient Care STDS"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.7448\/IAS.18.1.19906","article-title":"Pneumocystis pneumonia in HIV-positive patients in Spain: Epidemiology and environmental risk factors","volume":"18","author":"Diaz","year":"2015","journal-title":"J. Int. AIDS Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1469-0691.2009.02804.x","article-title":"Seasonal variation of Pneumocystis jirovecii infection: Analysis of underlying climatic factors","volume":"15","author":"Sing","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1258\/ijsa.2010.010148","article-title":"Seasonal variation in mortality of Pneumocystis jirovecii pneumonia in HIV-infected patients","volume":"21","author":"Miller","year":"2010","journal-title":"Int. J. STD AIDS"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/thx.2009.117846","article-title":"Prediciting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: An observational cohort study","volume":"64","author":"Fei","year":"2009","journal-title":"Thorax"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Weng, L., Huang, X., Chen, L., Feng, L.Q., Jiang, W., Hu, X.Y., Peng, J.M., Wang, C.Y., Zhan, Q.Y., and Du, B. (2016). Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: A bicentric retrospective study. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1855-x"},{"key":"ref_39","unstructured":"(2018, September 11). Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, Available online: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jac\/dkw155","article-title":"Fifth European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Cordonnier","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_42","unstructured":"(2016, October 11). Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Available online: https:\/\/aidsetc.org\/disclaimer."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"5th European Conference on Infections in Leukaemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organisation for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN). ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Pneumocystis pneumonia in Solid organ transplantation","volume":"13","author":"Martin","year":"2013","journal-title":"Am. J. Translant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4103\/0366-6999.189068","article-title":"Relationship between radiological stages and prognoses of Pneumocystis pneumonia in Non-AIDS immunocompromised patients","volume":"129","author":"Mu","year":"2016","journal-title":"J. Chin. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1259\/bjr\/39696316","article-title":"Differences and similarities of cytomegalovirus and Pneumocystis pneumonia in HIV-negative immunocompromised patients thin section CT morphology in the early phase of the disease","volume":"80","author":"Vogel","year":"2007","journal-title":"Br. J. Radiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia","volume":"96","author":"Salzer","year":"2018","journal-title":"Respiration"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"w13184","DOI":"10.4414\/smw.2011.13184","article-title":"Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia","volume":"141","author":"Vogel","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"ref_49","first-page":"510","article-title":"Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP","volume":"10","author":"Nyamande","year":"2006","journal-title":"Int. J. Tuberc. Lund Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"E01186-14","DOI":"10.1128\/mBio.01186-14","article-title":"Pneumocystis jiroveci can be productively cultured in differentiated CuFi-8 airway cells","volume":"5","author":"Schildgen","year":"2014","journal-title":"Mbio"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.02.01372002","article-title":"Meta-analysis of diagnostic procedures for Pneumocystis carnii pneumonia in HIV-1-infected patients","volume":"20","author":"Cruciani","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3760\/cma.j.issn.0366-6999.20122506","article-title":"Use of real-time polymerase chain reaction for the diagnosis of Pneumocystis pneumonia in immuncompromised patients: A meta-analysis","volume":"126","author":"Summah","year":"2013","journal-title":"J. Chin. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Fan, L.-C., Lu, H.-W., Cheng, K.-B., Li, H.-P., and Xu, J.-F. (2013). Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: A bivariate meta-analysis and systematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073099"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/JCM.06066-11","article-title":"PCR Diagnosis of Pneumocystis pneumonia: A bivariate meta-analysis","volume":"49","author":"Lu","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JCM.02876-15","article-title":"Performances of four real-time PCR assays for the diagnosis of Pneumocystis jirovecii Pneumonia","volume":"54","author":"Sasso","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-0691.2011.03760.x","article-title":"Accuracy of \u03b2-d-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: A meta-analysis","volume":"19","author":"Karageorgopoulos","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic Accuracy of Serum 1,3-\u03b2-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_58","first-page":"2214","article-title":"Diagnosis of Pneumocystis pneumonia using serum (1-3)-\u03b2-d-Glucan:a bivariate meta-analysis and systematic review","volume":"7","author":"Li","year":"2015","journal-title":"Thorac. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JCM.01554-13","article-title":"Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1-3)-\u03b2-d-glucan for differential diagnosis of Pneumocystis pneumonia and Pneumocystis colonisation","volume":"51","author":"Damiani","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2014.04.008","article-title":"The utility of bronchoalveolar lavage \u03b2-d-glucan testing for the diagnosis of invasive fungal infections","volume":"69","author":"Rose","year":"2014","journal-title":"J. Infect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.rmed.2014.09.017","article-title":"Serum and BAL \u03b2-d-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients","volume":"108","author":"Salerno","year":"2014","journal-title":"Respir. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison with Antigen Testing","volume":"61","author":"White","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MCP.0b013e3283455c0b","article-title":"Pulmonary infectious diseases in patients with primary immunodeficiency and those treated with biologic immunomodulating agents","volume":"17","author":"Alvarez","year":"2011","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/annrheumdis-2013-203407","article-title":"Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: Results of the SAfety Assessment of Biologic ThERapy (SABER) Study","volume":"73","author":"Baddley","year":"2014","journal-title":"Ann Rheum. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for Pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann. Rheum. Dis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: Systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) (2010). Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells\/mL?. Clin. Infect. Dis., 51, 611\u2013619.","DOI":"10.1086\/655761"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/323129","article-title":"Prevention of infection caused by Pneumocystis carinii in transplant recipients","volume":"33","author":"Fishman","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care kidney transplant recipients: A summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1097\/TXD.0000000000000665","article-title":"Lifelong Prophylaxis with Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients","volume":"3","author":"Goto","year":"2017","journal-title":"Transplant. Direct."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Faure, E., Lionet, A., Kipnis, E., Noel, C., and Hazzan, M. (2017). Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation. Transplant. Infect. Dis., 19.","DOI":"10.1111\/tid.12735"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Stern, A., Green, H., Paul, M., Vidal, L., and Leibovici, L. (2014). Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst. Rev., 1.","DOI":"10.1002\/14651858.CD005590.pub3"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/tid.12457","article-title":"Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation","volume":"17","author":"Evans","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1111\/j.1600-6143.2005.01079.x","article-title":"Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1086\/314509","article-title":"Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure","volume":"178","author":"Walker","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/318835","article-title":"Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS","volume":"183","author":"Kazanjian","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciy154","article-title":"Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients","volume":"67","author":"Argy","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1083-8791(00)70050-4","article-title":"Aerosolized pentamidine as Pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections","volume":"6","author":"Vasconcelles","year":"2000","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/313509","article-title":"High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receivingdapsone prophylaxis","volume":"29","author":"Souza","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1702004","article-title":"A prospective randomized trial comparing the toxicity and safety of atovaquone with SXTas Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation","volume":"24","author":"Colby","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-017-0664-6","article-title":"Pneumocystis Pneumonia and the Rheumatologist: Which Patients are at Risk and How Can PCP Be Prevented?","volume":"19","author":"Wolfe","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar4472","article-title":"Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study","volume":"16","author":"Katsuyama","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_83","first-page":"490","article-title":"Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases","volume":"36","author":"Baulier","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/ijd.13396","article-title":"Weighing the risks and benefits of Pneumocystis pneumonia prophylaxis in iatrogenically immunosuppressed dermatology patients","volume":"56","author":"Lehman","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fped.2017.00161","article-title":"Pneumocystis jirovecii Pneumonia in pediatric inflammatory bowel disease: A Case report and literature review","volume":"5","author":"Lawrence","year":"2017","journal-title":"Front Pediatr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/AAC.00017-11","article-title":"Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures","volume":"55","author":"Cushion","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3892\/etm.2015.2929","article-title":"Adjunctive corticosteroids for the treatment of Pneumocystis jiroveci pneumonia in patients with HIV: A meta-analysis","volume":"11","author":"Wang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zolopa, A., Andersen, J., Powderly, W., Sanchez, A., Sanne, I., Suckow, C., Hogg, E., and Komarow, L. (2009). Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: A multicenter randomized strategy trial. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005575"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kosaka, M., Ushiki, A., Ikuyama, Y., Hirai, K., Matsuo, A., Hachiya, T., and Hanaoka, M. (2017). A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.01173-17"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.07-0223","article-title":"Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients","volume":"132","author":"Bollee","year":"2007","journal-title":"Chest"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-14-87","article-title":"Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia","volume":"14","author":"Lemiale","year":"2013","journal-title":"Respir. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.1097\/TXD.0000000000000642","article-title":"A Systematic Review and Meta-Analysis of the Data Behind Current Recommendations for Corticosteroids in Non-HIV-Related PCP: Knowing When You Are on Shaky Foundations","volume":"3","author":"Injean","year":"2017","journal-title":"Transplant. Direct."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.chest.2018.04.026","article-title":"Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated with Better Outcome","volume":"154","author":"Wieruszewski","year":"2018","journal-title":"Chest"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10096-006-0149-4","article-title":"Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients","volume":"25","author":"Torres","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1086\/517099","article-title":"Persistence of Pneumocystis carinii after effective treatment of P. carinii pneumonia is not related to relapse or survival among patients infected with human immunodeficiency virus infection","volume":"26","author":"Roger","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Crit. Care"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcrc.2009.04.001","article-title":"Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: A still pending question","volume":"25","author":"Soares","year":"2010","journal-title":"J. Crit. Care"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021","volume":"327","author":"Hardy","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group","volume":"327","author":"Schneider","year":"1992","journal-title":"N. Engl. J. Med"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/jac\/dkx198","article-title":"Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii","volume":"72","author":"Robin","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/cid\/ciw028","article-title":"Efavirenz but Not Atazanavir\/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects","volume":"62","author":"Penzak","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s15010-017-1005-4","article-title":"Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort","volume":"45","author":"Roderus","year":"2017","journal-title":"Infection"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3347\/kjp.2015.53.3.321","article-title":"A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole","volume":"53","author":"Lee","year":"2015","journal-title":"Korean J. Parasitol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3201\/eid0907.020753","article-title":"Sulfa Resistance and Dihydropteroate Synthase Mutants in Recurrent Pneumocystis carinii Pneumonia","volume":"9","author":"Nahimana","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(99)03320-6","article-title":"Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia","volume":"354","author":"Benfield","year":"1999","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ponce, C.A., Chab\u00e9, M., George, C., C\u00e1rdenas, A., Dur\u00e1n, L., Guerrero, J., Bustamante, R., Matos, O., Huang, L., and Miller, R.F. (2017). High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.01290-16"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3343\/lmo.2016.6.4.250","article-title":"A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to SXT in the Absence of Previous Drug Exposure","volume":"6","author":"Ahn","year":"2016","journal-title":"Lab. Med. Online"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3892\/etm.2014.2002","article-title":"Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia","volume":"8","author":"Long","year":"2014","journal-title":"Exp.Ther. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1086\/655145","article-title":"Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations","volume":"51","author":"Hauser","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/315824","article-title":"Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene","volume":"182","author":"Huang","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.diagmicrobio.2016.10.005","article-title":"Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations","volume":"87","author":"Montesinos","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2016.01.018","article-title":"Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: Evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control","volume":"93","author":"Yiannakis","year":"2016","journal-title":"J. Hosp. Infect."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1128\/JCM.39.11.3877-3882.2001","article-title":"Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia","volume":"39","author":"Miller","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/653933","article-title":"Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia","volume":"51","author":"Choukri","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/513198","article-title":"An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: Interhuman transmission or a common environmental source?","volume":"44","author":"Gaasbeek","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.2013.212","article-title":"Post-transplant Pneumocystis jirovecii pneumonia\u2014A re-emerged public health problem?","volume":"84","author":"Chapman","year":"2013","journal-title":"Kidney Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/jcm.35.10.2511-2513.1997","article-title":"Detection of Pneumocystis carinii DNA in air samples: Likely environmental risk to susceptible persons","volume":"35","author":"Bartlett","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/JCM.36.6.1737-1740.1998","article-title":"Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments","volume":"36","author":"Olsson","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/rheumatology\/kes244","article-title":"Pneumocystis jirovecii infection: An emerging threat to patients with rheumatoid arthritis","volume":"51","author":"Mori","year":"2012","journal-title":"Rheumatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/TP.0b013e3181aed389","article-title":"Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host","volume":"88","author":"Yazaki","year":"2009","journal-title":"Transplantation"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/JCM.36.3.734-741.1998","article-title":"Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes","volume":"36","author":"Lee","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0929-6646(08)60199-0","article-title":"Pneumocystis pneumonia","volume":"107","author":"Lu","year":"2008","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fmicb.2016.00733","article-title":"Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing","volume":"7","author":"Alanio","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Gits-Muselli, M., Peraldi, M.N., de Castro, N., Delcey, V., Menotti, J., Guigue, N., Hamane, S., Raffoux, E., Bergeron, A., and Valade, S. (2015). New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125763"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199503233321219","article-title":"Maternal-fetal transmission of Pneumocystis carinii in human immunodeficiency virus infection","volume":"332","author":"Mortier","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(98)07204-3","article-title":"Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy","volume":"353","author":"Schneider","year":"1999","journal-title":"Lancet"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/crj.12467","article-title":"Pneumocystis pneumonia in non-HIV children: A 10-year retrospective study","volume":"12","author":"Ling","year":"2018","journal-title":"J. Clin. Respir."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1038\/ncomms10740","article-title":"Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts","volume":"22","author":"Ma","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/4\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:06:02Z","timestamp":1775279162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/4\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":128,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["jof4040127"],"URL":"https:\/\/doi.org\/10.3390\/jof4040127","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]}}}